title: Reply: To PMID 25371395.
authors.affiliation: Feinstein Institute for Medical Research, Manhasset, NY.
authors.forename: Peter K
authors.initials: PK
authors.lastname: Gregersen
authors.affiliation: Feinstein Institute for Medical Research, Manhasset, NY.
authors.forename: Michaela
authors.initials: M
authors.lastname: Oswald
authors.affiliation: Janssen Research and Development, Springhouse, PA.
authors.forename: Mark
authors.initials: M
authors.lastname: Curran
authors.affiliation: Biogen Idec, Cambridge, MA.
authors.forename: John
authors.initials: J
authors.lastname: Carulli
mesh_terms: D018501:Antirheumatic Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000235:genetics*; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects*; D006801:Humans; D008297:Male; D012313:RNA / Q000097:blood*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D012313:RNA